Zotero PDF Inventory

Storage path: /Volumes/home/zotero

• Total PDFs: 154
• Attachment keys: 154
• Total size: 865.2 MB

Recent PDFs

• XXMPWAFB / 2026 - Clinical Lung Cancer - Takeda et al. - Durvalumab After Chemoradiotherapy for Locally Advanced NSCLC A Real-World Analysis Using a Nationwide Claims Database in Japan.pdf (0.7 MB, zip)
• YCHN5LZP / 2020 - Histopathology - Koomen et al. - Comparability of PD‐L1 immunohistochemistry assays for non‐small‐cell lung cancer a systematic review.pdf (0.2 MB, zip)
• UIYUBNDN / 2024 - JAMA Netw Open - Mooradian et al. - Durvalumab After Chemoradiotherapy in Patients With Unresectable Stage III Non–Small Cell Lung Cancer.pdf (0.9 MB, zip)
• PJYFYPIR / 2023 - Current Oncology - Moore et al. - Durvalumab Treatment Patterns for Patients with Unresectable Stage III Non-Small Cell Lung Cancer in the Veterans Health Administration (VHA) A Nationwide, Real-World Study.pdf (0.6 MB, zip)
• KGDEC8N3 / 2026 - Clinical Lung Cancer - Takeda et al. - Durvalumab After Chemoradiotherapy for Locally Advanced NSCLC A Real-World Analysis Using a Nationwide Claims Database in Japan.pdf (0.7 MB, zip)
• JIIJVXB3 / PIIS2405630822000726.pdf (0.6 MB, zip)
• J8W8EPWU / 2022 - European Journal of Cancer - Bryant et al. - De-escalating adjuvant durvalumab treatment duration in stage III non-small cell lung cancer.pdf (0.8 MB, zip)
• 7V3ELCS6 / 2026 - Clinical Lung Cancer - Takeda et al. - Durvalumab After Chemoradiotherapy for Locally Advanced NSCLC A Real-World Analysis Using a Nationwide Claims Database in Japan.pdf (0.7 MB, zip)
• D97ZYIKH / 2023 - Cancers - Stana et al. - Chemo-Radio-Immunotherapy for NSCLC III ESRATS Thresholds for DLCO Correlate with Radiation Dosimetry and Pneumonitis Rate.pdf (3.3 MB, zip)
• YW6KJIKY / 2017 - CA A Cancer J Clinicians - Amin et al. - The Eighth Edition AJCC Cancer Staging Manual Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging.pdf (0.1 MB, zip)
• WZ8RMR3T / 2020 - Annals of Oncology - Paz-Ares et al. - Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial.pdf (0.5 MB, zip)
• UJZXBZCL / 2025 - Lung Cancer - Crespi et al. - Real-world outcomes of subsequent treatment strategies after durvalumab consolidation in stage III unresectable non-small cell lung cancer.pdf (2.0 MB, zip)
• T7I2TC7J / 2016 - Circulation - Austin et al. - Introduction to the Analysis of Survival Data in the Presence of Competing Risks.pdf (0.3 MB, zip)
• SXP8DZRT / 2020 - Lung Cancer - Jung et al. - Real world data of durvalumab consolidation after chemoradiotherapy in stage III non-small-cell lung cancer.pdf (1.5 MB, zip)
• ST6647XS / 2007 - American Journal of Epidemiology - Vittinghoff and McCulloch - Relaxing the Rule of Ten Events per Variable in Logistic and Cox Regression.pdf (0.2 MB, zip)
• NJ4AKQDY / 1-s2.0-S0360301621034222-main.pdf (0.9 MB, zip)
• KES7TB62 / 2023 - Cancers - Stana et al. - Chemo-Radio-Immunotherapy for NSCLC III ESRATS Thresholds for DLCO Correlate with Radiation Dosimetry and Pneumonitis Rate.pdf (3.3 MB, zip)
• N5FZZJZY / 2017 - N Engl J Med - Antonia et al. - Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer.pdf (0.3 MB, zip)
• MNCW2DFY / 2013 - JCO - Giobbie-Hurder et al. - Challenges of Guarantee-Time Bias.pdf (0.2 MB, zip)
• JPJ664D5 / 2024 - Sci Rep - Sugimoto et al. - Derived neutrophil-to-lymphocyte ratio has the potential to predict safety and outcomes of durvalumab after chemoradiation in non-small cell lung cancer.pdf (2.5 MB, zip)
• K6RXVXSL / 2023 - Journal of Thoracic Oncology - Naidoo et al. - Brief Report Durvalumab After Chemoradiotherapy in Unresectable Stage III EGFR-Mutant NSCLC A Post Hoc Subgroup Analysis From PACIFIC.pdf (0.5 MB, zip)
• JKAKMGYV / 2023 - Journal of Thoracic Oncology - Park et al. - Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy PACIFIC-KR.pdf (0.5 MB, zip)
• I39FUEC6 / 1-s2.0-S0169500221005201-main.pdf (1.2 MB, zip)
• BXPZLDG6 / 2017 - Journal of Thoracic Oncology - Hirsch et al. - PD-L1 Immunohistochemistry Assays for Lung Cancer Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project.pdf (6.6 MB, zip)
• FT4IVSSU / 1996 - Journal of Clinical Epidemiology - Sun et al. - Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis.pdf (1.2 MB, zip)
• 87IUPXS8 / 2023 - Clinical and Translational Radiation Oncology - Pennock et al. - Exploring causes and consequences of early discontinuation of durvalumab after chemoradiotherapy for non-small cell lung cancer.pdf (0.7 MB, zip)
• 2HNTUS5W / 2024 - N Engl J Med - Lu et al. - Osimertinib after Chemoradiotherapy in Stage III EGFR -Mutated NSCLC.pdf (0.7 MB, zip)
• 42VFJTKL / 2024 - Br J Cancer - Haratani et al. - Association of immune-related adverse events with durvalumab efficacy after chemoradiotherapy in patients with unresectable Stage III non-small cell lung cancer.pdf (0.7 MB, zip)
• 3FQ5QB6Q / 1-s2.0-S1556086422018536-main.pdf (0.6 MB, zip)
• H9EK7HZN / 1-s2.0-S1556086422018536-main.pdf (0.6 MB, zip)
• QUH8N6R9 / 2022 - JCO - Spigel et al. - Five-Year Survival Outcomes From the PACIFIC Trial Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer.pdf (0.8 MB, zip)
• 486VGDNF / 2023 - Journal of Thoracic Oncology - Park et al. - Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy PACIFIC-KR.pdf (0.5 MB, zip)
• Q8FHTYKG / 1-s2.0-S0169500226006276-main.pdf (2.8 MB, zip)
• UJDE5BSY / jama_zhou_2026_oi_260066_1785789475.4232.pdf (0.6 MB, zip)
• P68JQT2U / 2026 - Eur Radiol - Dinnessen et al. - Multicentre performance and consistency of two deep learning models for malignancy probability estimation of incidental pulmonary nodules.pdf (1.9 MB, zip)
• F8WESJ3I / 2018 - N. Engl. J. Med. - Hellmann et al. - Nivolumab plus ipilimumab in lung cancer with a high tumor mutational burden.pdf (0.5 MB, zip)
• DZT9MRW4 / 2020 - N. Engl. J. Med. - Herbst et al. - Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC.pdf (0.5 MB, zip)
• P3VXKFKD / 2021 - Ann. Oncol. - Remon et al. - Early and locally advanced non-small-cell lung cancer an update of the ESMO Clinical Practice Guidelines focusing on diagnosis, staging, systemic and local therapy.pdf (0.4 MB, zip)
• LWM6MUFZ / 2026 - J Immunother Cancer - Tran et al. - Combined circulating tumor antigen model demonstrates additional prognostic value in first-line treatment of non-small cell lung cancer.pdf (2.6 MB, zip)
• 4HW7E4XF / 274e36b9-aa51-40d5-92f8-2e0ee3e0f313.pdf (6.5 MB, zip)
• 8JCQ54BG / 2026 - Lung Cancer - Adar et al. - Sublobar resection, stereotactic body radiotherapy, and thermal ablation for early-stage non-small cell lung cancer a systematic review and meta-analysis.pdf (4.0 MB, zip)
• 8HZ2MT4V / 2026 - npj Digit. Med. - Li et al. - Interpretable multimodal deep learning for time-resolved survival prediction after hepatocellular carcinoma resection.pdf (3.0 MB, zip)
• NJUIPPLZ / 2022 - The Lancet - Bos and Ware - Acute respiratory distress syndrome causes, pathophysiology, and phenotypes.pdf (2.6 MB, zip)
• RYSFXDIC / 2022 - j intensive care - Tasaka et al. - ARDS Clinical Practice Guideline 2021.pdf (1.7 MB, zip)
• IQE4WWQ6 / s00134-022-06809-8 (1).pdf (2.1 MB, zip)
• 8PUC64RH / 2022 - Intensive Care Med - Belletti et al. - Air leak, barotrauma susceptibility, and imaging in acute respiratory distress syndrome novel application of an old tool.pdf (0.5 MB, zip)
• LR8VI4VM / bjr.20160723.pdf (3.2 MB, zip)
• DJE45J9G / 1-s2.0-S0883944121001696-main.pdf (1.2 MB, zip)
• 7XZB5HBD / 2022 - CHEST - Cherian et al. - Algorithmic Approach to the Diagnosis of Organizing Pneumonia.pdf (11.8 MB, zip)
• 5XXFG8QJ / 2022 - The Lancet - Bos and Ware - Acute respiratory distress syndrome causes, pathophysiology, and phenotypes.pdf (2.5 MB, zip)
• N9KWVJBV / Acute-respiratory-distress-syndrome-in-adults--dia.pdf (0.8 MB, zip)
• 4FJPAQ4Z / 2026 - Lung Cancer - Adar et al. - Sublobar resection, stereotactic body radiotherapy, and thermal ablation for early-stage non-small cell lung cancer a systematic review and meta-analysis.pdf (4.0 MB, zip)
• JBGPFXJ8 / 2020 - J. Immunother. Cancer. - He et al. - Predicting response to immunotherapy in advanced non-small-cell lung cancer using tumor mutational burden radiomic biomarker.pdf (5.1 MB, zip)
• Y2Z56LHS / 2021 - Korean J. Radiol. - Nam et al. - Tissue adequacy and safety of percutaneous transthoracic needle biopsy for molecular analysis in non-small cell lung cancer a systematic review and meta-analysis.pdf (2.0 MB, zip)
• LR7F9XFC / 2015 - PLoS One - Saito and Rehmsmeier - The precision-recall plot is more informative than the ROC plot when evaluating binary classifiers on imbalanced datasets.pdf (1.2 MB, zip)
• YCWQ4XGV / 2020 - Cancer Manag. Res. - Deng et al. - PD-L1 Expression is Highly Associated with Tumor-Associated Macrophage Infiltration in Nasopharyngeal Carcinoma.pdf (3.4 MB, zip)
• ZD6EXFHN / 2024 - J. Breast Cancer - Jung et al. - Omission of Breast Surgery in Predicted Pathologic Complete Response after Neoadjuvant Systemic Therapy A Multicenter, Single-Arm, Non-inferiority Trial.pdf (2.2 MB, zip)
• Z3AR8VMW / 2023 - Zheng et al. - Making the Most Out of the Limited Context Length Predictive Power Varies with Clinical Note Type and Note Section.pdf (0.3 MB, zip)
• 7NCC3PIA / 2017 - J. Immunother. Cancer. - Danaher et al. - Gene expression markers of Tumor Infiltrating Leukocytes.pdf (1.5 MB, zip)
• BMU462K5 / 2009 - J. Nucl. Med. - Wahl et al. - From RECIST to PERCIST Evolving Considerations for PET response criteria in solid tumors.pdf (1.0 MB, zip)
• XDCEMBJV / 2020 - PLoS One - Yoon et al. - Deciphering the tumor microenvironment through radiomics in non-small cell lung cancer Correlation with immune profiles.pdf (1.4 MB, zip)
• VL44VKPI / 2019 - BMC Med. - Van Calster et al. - Calibration the Achilles heel of predictive analytics.pdf (0.6 MB, zip)
• VIG4DYUC / 2011 - Korean J. Radiol. - Cheung et al. - Combined fluoroscopy-and CT-guided transthoracic needle biopsy using a C-arm cone-beam CT system comparison with fluoroscopy-guided biopsy.pdf (0.2 MB, zip)
• ACN9V7SB / 2024 - Liu et al. - DoRA Weight-decomposed low-rank adaptation.pdf (7.5 MB, zip)
• SIC9FNX6 / 2023 - Dao - FlashAttention-2 Faster attention with better parallelism and work partitioning.pdf (1.6 MB, zip)
• LGS65WMH / 2019 - Eur. Respir. J. - Shin et al. - Which definition of a central tumour is more predictive of occult mediastinal metastasis in nonsmall cell lung cancer patients with radiological N0 disease.pdf (0.7 MB, zip)
• ILFVAPCG / 2015 - Kingma and Ba - Adam A method for stochastic optimization.pdf (0.6 MB, zip)
• FLG4KQMF / 2016 - K. He et al. - Deep Residual Learning for Image Recognition.pdf (6.0 MB, zip)
• UKC25JAU / 2025 - Eur. Respir. J. - Ryerson et al. - Update of the international multidisciplinary classification of the interstitial pneumonias an ERSATS statement.pdf (8.0 MB, zip)
• BIQBWPV9 / 2019 - Acta Oncol. - Reiniger et al. - Tumor necrosis correlates with PD-L1 and PD-1 expression in lung adenocarcinoma.pdf (0.8 MB, zip)
• XBQNF56P / 2021 - Ann. Oncol. - Loi et al. - The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer clinical utility in an era of checkpoint inhibition.pdf (2.2 MB, zip)
• 7TI4MW8D / 2024 - Demircioglu - The effect of feature normalization methods in radiomics.pdf (4.3 MB, zip)
• UB3TDSDG / 2017 - CA Cancer J. Clin. - Amin et al. - The Eighth Edition AJCC Cancer Staging Manual Continuing to build a bridge from a population-based to a more personalized approach to cancer staging.pdf (0.1 MB, zip)
• H3KDM6PN / 2016 - J. Thorac. Oncol. - Goldstraw et al. - The IASLC Lung Cancer Staging Project Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer.pdf (0.6 MB, zip)
• A6BRD5FR / 2019 - Nat. Commun. - Wang et al. - The Aryl hydrocarbon receptor mediates tobacco-induced PD-L1 expression and is associated with response to immunotherapy.pdf (5.7 MB, zip)
• 9MYUSZ43 / 2023 - Histopathology - Huyuk et al. - Systematic review and meta-analysis of the prognostic impact of lymph node micrometastasis and isolated tumour cells in patients with stage I-IIIA non-small cell lung cancer.pdf (0.7 MB, zip)
• ZEA2GCKB / 2025 - Eur. Radiol. - Lee et al. - Risk factors and prognostic indicators for progressive fibrosing interstitial lung disease a deep learning-based CT quantification approach.pdf (3.7 MB, zip)
• M3IDHZXJ / 2013 - J. Thorac. Oncol. - Subramanian et al. - Review of ongoing clinical trials in non-small-cell lung cancer a status report for 2012 from the ClinicalTrials.gov Web site.pdf (0.1 MB, zip)
• CLPJ6RHK / 2023 - Potter et al. - Recurrence After Complete Resection for Non-Small Cell Lung Cancer in the National Lung Screening Trial.pdf (1.2 MB, zip)
• KDZ4TDG8 / 2024 - Chest - Rajaram et al. - Recurrence-Free Survival in Patients With Surgically Resected Non-Small Cell Lung Cancer A Systematic Literature Review and Meta-Analysis.pdf (0.8 MB, zip)
• S5YFVZFT / 2023 - Jang et al. - Radiologic Extranodal Extension of Metastatic Lymph Nodes in Patients With Non-Small Cell Lung Cancer Prognostic Utility and Diagnostic Performance.pdf (1.1 MB, zip)
• N8U58FSL / 2019 - J. Thorac. Oncol. - Ferrara et al. - Pseudoprogression in Non-Small Cell Lung Cancer upon Immunotherapy Few Drops in the Ocean.pdf (0.2 MB, zip)
• AR4XCH27 / 2026 - Chest - Park et al. - Quantitative CT Imaging in Progressive Pulmonary Fibrosis Clinical Usefulness and Meaningful Threshold Definition.pdf (0.8 MB, zip)
• CT8QS9Q8 / 2022 - Acta Oncol. - Haque et al. - Quantifying the rate and predictors of occult lymph node involvement in patients with clinically node-negative non-small cell lung cancer.pdf (0.8 MB, zip)
• XP88M2U3 / 2015 - N. Engl. J. Med. - Garon et al. - Pembrolizumab for the treatment of non-small-cell lung cancer.pdf (0.7 MB, zip)
• REA7GAXY / 2018 - N. Engl. J. Med. - Gandhi et al. - Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.pdf (0.5 MB, zip)
• EZCJ3PJK / 2006 - Licker et al. - Operative mortality and respiratory complications after lung resection for cancer impact of chronic obstructive pulmonary disease and time trends.pdf (0.1 MB, zip)
• 34ULQHFP / 2024 - Front. Immunol. - Qu et al. - Non-invasive prediction for pathologic complete response to neoadjuvant chemoimmunotherapy in lung cancer using CT-based deep learning a multicenter study.pdf (6.0 MB, zip)
• BQXA6QVY / 2026 - J. Natl. Compr. Canc. Netw. - Riely et al. - Non–Small Cell Lung Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology.pdf (1.4 MB, zip)
• EUUC62QG / 2024 - JAMA Netw. Open - Zhou et al. - Neoadjuvant-Adjuvant vs Neoadjuvant-Only PD-1 and PD-L1 Inhibitors for Patients With Resectable NSCLC An Indirect Meta-Analysis.pdf (1.0 MB, zip)
• UGSUA6Q2 / 2022 - N. Engl. J. Med. - Forde et al. - Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer.pdf (0.7 MB, zip)
• TIMVXAEZ / 2024 - JAMA Oncol. - Sorin et al. - Neoadjuvant Chemoimmunotherapy for NSCLC A Systematic Review and Meta-Analysis.pdf (0.5 MB, zip)
• UWGB38E3 / 2023 - Radiology - Khader et al. - Multimodal deep learning for integrating chest radiographs and clinical parameters a case for transformers.pdf (2.0 MB, zip)
• PYJ79ZT2 / 2025 - Wang and Yang - MoE-Health A Mixture of Experts Framework for Robust Multimodal Healthcare Prediction.pdf (1.5 MB, zip)
• 9N7H4U5Q / 2014 - BMC Med. Res. Methodol. - Van Der Ploeg et al. - Modern modelling techniques are data hungry a simulation study for predicting dichotomous endpoints.pdf (2.5 MB, zip)
• MYK3X9AX / 2021 - J. Hematol. Oncol. - Wu et al. - Intratumor heterogeneity the hidden barrier to immunotherapy against MSI tumors from the perspective of IFN-gamma signaling and tumor-infiltrating lymphocytes.pdf (3.4 MB, zip)
• XAEI9R7S / 2021 - J. Thorac. Oncol. - Park et al. - Lung Cancer in Korea.pdf (1.1 MB, zip)
• WFID5G9L / 1984 - Mull - Mass estimates by computed tomography physical density from CT numbers.pdf (0.6 MB, zip)
• CE2UKQGV / 2022 - Front. Oncol. - Hao et al. - Immune checkpoint inhibitor-related pneumonitis in non-small cell lung cancer A review.pdf (0.5 MB, zip)
• 6P56CMNL / 2023 - Yolchuyeva et al. - Imaging-Based Biomarkers Predict Programmed Death-Ligand 1 and Survival Outcomes in Advanced NSCLC Treated With Nivolumab and Pembrolizumab A Multi-Institutional Study.pdf (1.1 MB, zip)
• 4NTFSF23 / 2017 - J. Thorac. Oncol. - Song et al. - Imaging Phenotyping Using Radiomics to Predict Micropapillary Pattern within Lung Adenocarcinoma.pdf (1.0 MB, zip)
• 9WHW9JZC / 2012 - Cancer Res. - Noman et al. - Hypoxia-inducible miR-210 regulates the susceptibility of tumor cells to lysis by cytotoxic T cells.pdf (2.7 MB, zip)
• 592TY2DY / 2022 - Front. Oncol. - Britt et al. - Hyperprogressive disease in non-small cell lung cancer treated with immune checkpoint inhibitor therapy, fact or myth.pdf (1.3 MB, zip)
• 2CMWGAA5 / 2023 - Nature - Jiang et al. - Health system-scale language models are all-purpose prediction engines.pdf (8.0 MB, zip)
• XYH9DJYH / 2022 - Cancer Discov. - Hanahan - Hallmarks of Cancer New Dimensions.pdf (5.6 MB, zip)
• CX2IGRHJ / 2021 - CA Cancer J. Clin. - Sung et al. - Global Cancer Statistics 2020 GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.pdf (2.6 MB, zip)
• MBB6LA7B / 2017 - Reuben et al. - Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma.pdf (2.5 MB, zip)
• RAZEXHM6 / 2021 - J. Thorac. Oncol. - Liu et al. - Efficacy and Safety of First-Line Immunotherapy Combinations for Advanced NSCLC A Systematic Review and Network Meta-Analysis.pdf (3.5 MB, zip)
• ZL9DXPXW / 2021 - Cancer Cell - Janjigian et al. - Eradicating micrometastases with immune checkpoint blockade Strike while the iron is hot.pdf (0.6 MB, zip)
• 6WWUHC2Y / 2022 - Chen et al. - Dynamic (18) F-FDG PETCT can predict the major pathological response to neoadjuvant immunotherapy in non-small cell lung cancer.pdf (7.8 MB, zip)
• C6LIWX9P / 2021 - Eur. Respir. J. - Nam et al. - Development and validation of a deep learning algorithm detecting 10 common abnormalities on chest radiographs.pdf (0.6 MB, zip)
• 6Y3P8VVB / 2018 - Sci. Rep. - Tang et al. - Development of an Immune-Pathology Informed Radiomics Model for Non-Small Cell Lung Cancer.pdf (1.8 MB, zip)
• 3WB64QE5 / 2022 - Oncol. Rep. - Sumitomo et al. - Differential expression of PD‑L1 and PD‑L2 is associated with the tumor microenvironment of TILs and M2 TAMs and tumor differentiation in non‑small cell lung cancer.pdf (2.9 MB, zip)
• 7EJIYE4V / 2025 - Clin. Radiol. - Xiong et al. - Delta-radiomics features combined with haematological index predict pathological complete response after neoadjuvant immunochemotherapy in resectable non-small cell lung cancer.pdf (1.8 MB, zip)
• FPIVXRWL / 2021 - JACC Cardiovasc. Imaging. - Raghu et al. - Deep Learning to Estimate Biological Age From Chest Radiographs.pdf (1.6 MB, zip)
• 7378ZYUC / 2022 - She et al. - Deep learning for predicting major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer A multicentre study.pdf (2.0 MB, zip)
• ZBF63KH7 / 2022 - Yang et al. - A large language model for electronic health records.pdf (1.6 MB, zip)
• NGFD6HRP / 2024 - Nat. Med. - Deutsch et al. - Association between pathologic response and survival after neoadjuvant therapy in lung cancer.pdf (4.6 MB, zip)
• WKQKME95 / 2018 - J. Thorac. Oncol. - Rocha et al. - CD103+CD8+ Lymphocytes Characterize the Immune Infiltration in a Case With Pseudoprogression in Squamous NSCLC.pdf (1.7 MB, zip)
• SFPQ69RR / 2022 - J. Clin. Oncol. - Park et al. - Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non-Small-Cell Lung Cancer.pdf (1.0 MB, zip)
• PVXATDJL / 2021 - Cancer Imaging - Lee et al. - Are radiomics features universally applicable to different organs.pdf (1.2 MB, zip)
• LMR52IMP / 2019 - Cancer Res. - Xiong et al. - Anti-PD-L1 Treatment Results in Functional Remodeling of the Macrophage Compartment.pdf (0.9 MB, zip)
• GZRKC6DQ / 2019 - Kim et al. - Comparison of the morphologic criteria (RECIST) and metabolic criteria (EORTC and PERCIST) in tumor response assessments a pooled analysis.pdf (0.3 MB, zip)
• ALXMWGH9 / 2011 - Austin - An introduction to propensity score methods for reducing the effects of confounding in observational studies.pdf (0.4 MB, zip)
• 49TXK94C / 2023 - Cancer - Leshem et al. - Association between diabetes mellitus and reduced efficacy of pembrolizumab in non-small cell lung cancer.pdf (0.5 MB, zip)
• 5JRX58ZT / 2023 - Front. Oncol. - Wang et al. - Advances in efficacy prediction and monitoring of neoadjuvant immunotherapy for non-small cell lung cancer.pdf (1.0 MB, zip)
• 2V4HQZKS / 2024 - Nat Rev Cancer - Rabas et al. - Cancer-induced systemic pre-conditioning of distant organs building a niche for metastatic cells.pdf (4.8 MB, zip)
• TQJTDU8V / 2025 - Lung Cancer - Chen et al. - Clinical outcomes and neuroendocrine features of transformed versus primary small-cell lung cancer.pdf (0.6 MB, zip)
• YLYLJJ7H / 2025 - JAMA Oncol - Saal et al. - Dissection of Progressive Disease Patterns for a Modified Classification for Immunotherapy.pdf (0.4 MB, zip)
• JFAM3IZL / 2025 - Mazzaschi et al. - Longitudinal Blood Immune-Inflammatory and Radiomic Profiling to Decode Different Patterns of Acquired Resistance to Immunotherapy in Patients with NSCLC.pdf (12.1 MB, zip)
• NX6ZDPX9 / 2021 - Annals of Oncology - Topp et al. - Lesion-level heterogeneity of radiologic progression in patients treated with pembrolizumab.pdf (0.5 MB, zip)
• NY5MMNAF / 2021 - RadioGraphics - Shur et al. - Radiomics in Oncology A Practical Guide.pdf (2.4 MB, zip)
• EB9D6VL8 / 2022 - Sci. Adv. - Wang et al. - Spatial interplay patterns of cancer nuclei and tumor-infiltrating lymphocytes (TILs) predict clinical benefit for immune checkpoint inhibitors.pdf (1.6 MB, zip)
• 663DJ7MD / 2023 - Sci. Adv. - Su et al. - Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets.pdf (2.8 MB, zip)
• BSRCJ23J / 1-s2.0-S0022522324001119-main.pdf (2.0 MB, zip)
• VRWHXIIA / 2024 - Sci Rep - Liu et al. - Efficacy of neoadjuvant immunochemotherapy and survival surrogate analysis of neoadjuvant treatment in IB–IIIB lung squamous cell carcinoma.pdf (2.2 MB, zip)
• WES8LNHG / 2022 - Sci Rep - Henry et al. - Investigation of radiomics based intra-patient inter-tumor heterogeneity and the impact of tumor subsampling strategies.pdf (3.6 MB, zip)
• VST5V469 / 2024 - BMC Med - Nie et al. - Obesity and survival in advanced non-small cell lung cancer patients treated with chemotherapy, immunotherapy, or chemoimmunotherapy a multicenter cohort study.pdf (3.9 MB, zip)
• T7E56IJY / 2025 - Pathology - Research and Practice - Chohan and Zaheer - Pathological extranodal extension in head and neck cancer A prognostic biomarker with therapeutic ramifications and diagnostic pitfalls.pdf (3.6 MB, zip)
• QE3ZNKBF / e012432.full.pdf (3.6 MB, zip)
• DTYUFBF6 / 2025 - Journal of Thoracic Oncology - Bang et al. - Perioperative Pembrolizumab for Locally Advanced Thymic Epithelial Tumors A Single-Arm, Phase 2 Trial.pdf (3.7 MB, zip)
• 2ETCKUUX / main.pdf (3.8 MB, zip)
• BTNAWZQY / Cha 등 - 2016 - Pulmonary Intravascular Lymphomatosis Clinical, CT, and PET Findings, Correlation of CT and Patholo.pdf (1.0 MB, zip)
• 3FZRLI45 / DeFreitas 등 - 2021 - Complications of Lung Transplantation Update on Imaging Manifestations and Management.pdf (2.7 MB, zip)
• LNLHIDSW / 2024 - Eur J Nucl Med Mol Imaging - Masse et al. - [18F]FDG-PETCT atypical response patterns to immunotherapy in non-small cell lung cancer patients long term prognosis assessment and clinical management proposal.pdf (1.2 MB, zip)
• SSTVFA2D / main.pdf (9.7 MB, zip)
• 8QB6KETI / 2025 - Nat Rev Clin Oncol - Lambin et al. - Radiomics Quality Score 2.0 towards radiomics readiness levels and clinical translation for personalized medicine.pdf (1.7 MB, zip)
• V992JTDG / Kim 등 - 2007 - Pulmonary involvement in Churg-Strauss syndrome an analysis of CT, clinical, and pathologic finding.pdf (0.3 MB, zip)
• MGJPLNLW / Henson 등 - 2024 - Criteria for the diagnosis of extranodal extension detected on radiological imaging in head and neck.pdf (1.1 MB, zip)
• FI7LAZXC / Cottin 등 - 2016 - Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg–Strauss).pdf (0.4 MB, zip)
• MPLYFA59 / Murray & Nadel's Textbook of Respiratory Medicine, 2-Volume Set, 6e ( PDFDrive ).pdf (554.4 MB, zip)
• 4LQ8RQQJ / 2023 - Jang et al. - Radiologic Extranodal Extension of Metastatic Lymph Nodes in Patients With Non–Small Cell Lung Cancer Prognostic Utility and Diagnostic Performance.pdf (1.1 MB, zip)
• 8WXNEH5B / 2025 - Forde et al. - Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer.pdf (0.7 MB, zip)
• 7UU6PVZE / 2025 - Nat Cancer - Awada et al. - The rapidly evolving paradigm of neoadjuvant immunotherapy across cancer types.pdf (2.1 MB, zip)